Notice for navepegritide (Specialised Therapeutics Pharma Pty Ltd)
Active ingredients
navepegritide
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
lyophilised powder in vial
Indication
Treatment of patients with achondroplasia
Therapeutic area
Endocrinology